EMA Authorised: Tecfidera (dimethyl fumarate) — Biogen Netherlands B.V.

View source ↗

Summary

The EMA has authorised Tecfidera (dimethyl fumarate) for use in multiple sclerosis; the marketing authorisation holder is Biogen Netherlands B.V.; decision date…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Tecfidera (dimethyl fumarate)

Snippet

Status: Authorised. Therapeutic area: Multiple Sclerosis. MAH: Biogen Netherlands B.V.. Decision date: 18/12/2024